Quick Facts
| Birth Date | June 11,1972 |
| Full Name | Scott Gottlieb |
| Profession | Physician |
| Nationality | American |
| Birth City | East Brunswick, New Jersey |
| Birth Country | United States |
| Father Name | Stanley Gottlieb |
| Father Profession | Psychiatrist |
| Mother Name | Marsha Gottlieb |
| Gender Identity | Male |
| Horoscope | Gemini |
| Marital Status | Married |
| Spouse | Allyson Brooke Nemeroff |
| No Of Children | 3 |
| Net worth | 390,000 |
| Education | Icahn School of Medicine |
| Wiki Link | |
| Facebook Link | |
| Twitter Link | |
| Insta Link |
Scott Gottlieb, M.D., is an American physician who served as the Food and Drug Administration’s 23rd Commissioner (FDA). From May 2017 through April 2019, he worked for the FDA. Scott is a partner with New Enterprise Associates, a venture capital firm. He also serves on the board of directors of Pfizer, Inc., a multinational pharmaceutical firm. Scott is also involved in a number other projects.
Gottlieb was born in New Jersey, United States, on June 11, 1972, to Dr. Stanley (father) and Marsha Gottlieb (mother). Scott, who is 48 years old, is of Jewish descent. Wesleyan University awarded him a bachelor’s degree in economics. Gottlieb also finished his internal medicine residency at Mount Sinai Hospital.
What is the Estimated Net Worth of Scott Gottlieb?
Scott Gottlieb has a net worth of $390,000 as of 2022, according to some reports. Several companies and investment firms paid Scott millions of dollars over the years, according to a New York Times article. From 2013 to 2015, he was paid over $150,000 to advise Vertex Pharmaceuticals. Mor Shapiro is another physician with a large net worth.
Scott has over 1000 Pfizer stock units worth over $140,840. He also makes $231,621 as a Pfizer independent director. Scott Gottlieb received roughly $90,000 in compensation as a Glaxo consultant in 2016, according to Gottlieb’s financial declarations provided by The Wall Street Journal. Gottlieb works in a variety of fields in addition to his job. He worked for the British Medical Journal as a staff writer. Scott also appears on CNBC on a regular basis.
Scott earned more than $3 million in 2016, according to the same documents. However, he received $1.85 million from T.R. Winston, a merchant bank, and $280,000 from New Enterprise Consulting. Scott is also the CEO of Cell Biotherapy, a cancer biotech company in its early stages.
